Glenmark Pharma gets USFDA nod for antiplatelet drug

Shares of Glenmark Pharma were trading 0.03 per cent higher at Rs 559.20 apiece on the BSE.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.